From clarifying which drugs are included in our PGx testing, what specimen type is preferred, and who to contact for more information, we’ve provided answers to facilitate test ordering.
What are the benefits of the Focused Pharmacogenomics Panel, PGXQP?
PGXQP tests only specific variants within genes with high evidence of drug-gene information.
What are the benefits of the Psychotropic Pharmacogenomics Gene Panel, PSYQP?
NOTE: If testing for one drug or one gene, a single gene or smaller pharmacogenomic test may occasionally be more appropriate (e.g., CYP2D6 for atomoxetine).
Who can I contact if I have questions on which test to order or understanding the results?
Our dedicated team of genetic counselors, pharmacists, pathologists, and laboratory geneticists is ready to help. Please contact Mayo Lab Inquiry (MLI) at 800-533-1710 for more information.
Where can I find more information on a specific drug?
To learn about medications included in our PGXQP and PSYQP panels, clients can search our online test catalog and open the sample report PDF to view the drugs included in the report.
Because pharmacogenomic results must be used in the context of a patient’s overall health, including other medications and co-morbidities, reports cannot provide exact dosing guidelines. View our Pharmacogenomic Association Tables to access publicly available information about drugs and pharmacogenomically relevant genes, including the FDA Table of Pharmacogenomic Associations, FDA drug labels, and gene-drug pairs from CPIC.
Why isn’t a drug included in the report?
We only include recommendations consistent with FDA labels or those reviewed by the Clinical Pharmacogenetics Implementation Consortium (CPIC). Some emerging gene-drug information is included in the PSYQP test and clearly indicated as such in the report. Single gene test reports generally do not include medication recommendations due to the many diverse potential clinical applications. Our Pharmacogenomic Association Tables summarize information on many drugs and can be a useful tool, particularly for single gene tests or when the PSYQP test is ordered for a patient who will be prescribed a non-psychotropic medication.
Certain drugs might not be included due to limited clinical evidence. We encourage prescribers to contact us at 800-533-1710 with questions.
Why is enhanced formatting not used for my report?
Enhanced report formatting is not supported by some institutions. A copy of the enhanced report can be faxed upon request.
Which test should be ordered to evaluate for a specific drug?
Refer to our Pharmacogenomic Association Tables to determine which genes may be of interest for a specific drug. CAUTION: We do not report medications for which there is limited gene-drug information, including drug metabolism, response, and/or toxicity. Pharmacogenomic pharmacists are a great resource when considering patient care and dosing recommendations.
What options are available for CYP2D6 gene testing?
Is blood or saliva the preferred specimen type?
In instances where the patient has undergone a transplant, is blood or saliva preferred?
Fill out the form below and one of our specialists will be in touch.